March 2013 | Page 2 Of 5 | Shrader & Associates L.L.P.
Get in Touch Today
866-262-8170

Conditional Approval of New Drug for British Mesothelioma Patients

by | Mar 25, 2013 | Mesothelioma

In 2011, the FDA approved the use of Xalkori (crizotinib) to treat patients who have late-stage, non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Recently, the European Commission also approved the drug, made by Pfizer, for this use. Now, researchers are working to determine whether this biomarker is also present in some patients with pleural...

View Article

New Study Challenges Heated Chemotherapy for Mesothelioma

by | Mar 25, 2013 | Mesothelioma

Experts are now saying that heated chemotherapy after mesothelioma surgery may not be as beneficial as originally hoped. A study on heated chemotherapy, also known as hyperthermic chemotherapy perfusion, was conducted by thoracic surgery researchers at the David Geffen School of Medicine shows that heat has little effect on most mesothelioma cells. The researchers studied three mesothelioma cell...

View Article

Emotional Side Effects: Panic Attacks

by | Mar 21, 2013 | Mesothelioma, Family Support

It’s natural and normal (and common) for patients with mesothelioma and other cancers to experience heightened fear and anxiety. Some patients feel anxiety because they fear treatment, are nervous about doctor visits, or are frightened about receiving negative test results. Others become fearful at the thought of pain, dying, or what will happen after they die, including what may happen to their...

View Article

Chemo Resistance May be Identified by New Biomarker

by | Mar 21, 2013 | Mesothelioma

The drug Xalkori, generic crizotinib, was approved last year for the treatment of patients with late-stage, non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma gene (less than 7% of patients). An unknown number of pleural mesothelioma patients also express this abnormal gene, so they could be benefitted by treatment with this drug. Chemotherapy is currently the most...

View Article

Complementary Therapy a Growing Option for Mesothelioma Patients

by | Mar 20, 2013 | Mesothelioma

When a person has cancer like mesothelioma, he or she is not simply fighting the disease: it’s also a battle against fatigue, stress, pain, and treatment side effects. While there are medications to help with many of these issues, patients and doctors are increasingly turning to complementary therapies for relief. When a treatment is used in tandem with traditional medical care, the American...

View Article